Side areas

Biosensors for pathogen diagnostics

Medical Technology/Digital HealthMedtech 2022

Brief description:
We are developing a new generation of in-vitro diagnostics for the detection of viruses, bacteria, etc. Using the latest molecular biology techniques, we reprogram microorganisms into powerful biosensors. Our biosensors make it possible to detect a large number of pathogens within a few minutes.

Services / products:
In-vitro diagnostics for the detection of microbial pathogens.

Founder:

  • Alexander Zwirzitz
  • Manuel Selg
  • Kevin Trenzinger
1_tech2b_dummy_logo_cross_format.jpg

Facts

CEO
Alexander Zwirzitz
Project start: 2022
Industry: Biotech
Employees: 3
Markets: worldwide
Biosensors for pathogen diagnostics
-
-
Tel: -
WordPress Cookie Plugin by Real Cookie Banner